Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes.
Ontology highlight
ABSTRACT: Introduction: Discontinuation of oral anticoagulants such as non-vitamin K antagonist oral anticoagulants (NOACs) may induce a hypercoagulable state, leading to severe stroke and poor outcomes. This study aimed to compare stroke outcomes between NOACs withdrawal and other prior medication statuses in patients with non-valvular atrial fibrillation (NVAF). Methods: Consecutive patients who had pre-existing NVAF and were admitted for an acute ischemic stroke or transient ischemic attack- at five hospitals between January 2013 and December 2016 were included. Prior medication status was categorized into seven groups such as no antithrombotics, antiplatelet-only, warfarin with subtherapeutic intensity, warfarin with therapeutic intensity, NOAC, warfarin withdrawal, and NOAC withdr
SUBMITTER: Park JH
PROVIDER: S-EPMC6305496 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA